Moreover, we have shown that the combination of perifosine and TRAIL exhibits enhanced effects on decreasing clonogenic survival and on inhibiting the growth of HNSCC xenograft in an orthotopic mouse model (Figure 1). This evidence concerns the gene TNFSF10 and head and neck squamous cell carcinoma.